Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Jefferies Maintains Hold on Eneti, Lowers Price Target to $21

Jefferies analyst Randy Giveans maintains Eneti (NYSE:NETI) with a Hold and lowers the price target from $22 to $21.

byBenzinga Newsdesk

August 19, 2021

1 minute read

Jefferies analyst Randy Giveans maintains Eneti (NYSE:NETI) with a Hold and lowers the price target from $22 to $21.

Needham Maintains Buy on DigitalOcean Holdings, Raises Price Target to $45

By Benzinga Newsdesk

Today, 11:41 PM

Needham analyst Mike Cikos maintains DigitalOcean Holdings (NYSE:DOCN) with a Buy and raises the price target from $36 to $45.

DOCN

Mid-Morning Market Update: Markets Rise; AstraZeneca’s COVID-19 Vaccine Turns Profitable In Third Quarter

By Lisa Levin

Today, 11:41 PM

Following the market opening Friday, the Dow traded up 0.25% to 36,012.29 while the NASDAQ rose 0.24% to 15,741.23. The S&P also rose, gaining 0.14% to 4,655.99.

AFIB

Unicef Signs COVID-19 Vaccine Supply Deal With J&J’s Janssen

By Benzinga Newsdesk

Today, 11:41 PM

-Reuters

JNJ

Atomera Shares Mark New Session Highs, Up 7.5%, Following Circulation Of Positive Research Report By Newsletter Provider, Disruptive Tech Research’s Lou Basenese

By Benzinga Newsdesk

Today, 11:41 PM

https://disruptivetr.com/2022/05/02/atom-lands-another-major-foundry/?utm_source=rss&utm_medium=rss&utm_campaign=atom-lands-another-major-foundry

ATOM

Jefferies Maintains Hold on Eneti, Lowers Price Target to $21

Related Posts

Needham Maintains Buy on DigitalOcean Holdings, Raises Price Target to $45

Mid-Morning Market Update: Markets Rise; AstraZeneca’s COVID-19 Vaccine Turns Profitable In Third Quarter

Unicef Signs COVID-19 Vaccine Supply Deal With J&J’s Janssen

Atomera Shares Mark New Session Highs, Up 7.5%, Following Circulation Of Positive Research Report By Newsletter Provider, Disruptive Tech Research’s Lou Basenese